How to buy Abcellera Biologics Inc (ABCL) stocks

Abcellera Biologics Inc is a biotechnology business based in the US. Abcellera Biologics Inc shares (ABCL) are listed on the NASDAQ and all prices are listed in US Dollars.

Its last market close was $2.85 – an increase of 1.42% over the previous week. Abcellera Biologics Inc employs 586 staff and has a trailing 12-month revenue of around $33 million.

Our top picks for where to buy Abcellera Biologics Inc stock

Buy AbCellera Biologics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Related: Compare the best stock trading platforms in Canada

Abcellera Biologics Inc stock price (NASDAQ: ABCL)

Use our graph to track the performance of ABCL stocks over time.

Abcellera Biologics Inc stocks at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$2.85
52-week range	$2.34 - $6.06
50-day moving average more info button	$2.79
200-day moving average more info button	$3.26
Wall St. target price	$12.29
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.61

Is it a good time to buy Abcellera Biologics Inc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dive deeper: Our picks for the best stocks to buy right now in Canada

Abcellera Biologics Inc price performance over time

Historical closes compared with the close of $2.85 from 2024-12-20

1 week (2024-12-12)	-3.39%
1 month (2024-11-21)	4.78%
3 months (2024-09-20)	10.04%
6 months (2024-06-21)	-1.72%

1 year (2023-12-21)	-49.91%
2 years (2022-12-21)	-73.11%
3 years (2021-12-21)	15.74
5 years (2019-12-18)	N/A

Abcellera Biologics Inc financials

Revenue TTM	$33 million
Gross profit TTM	$311.1 million
Return on assets TTM	-13.26%
Return on equity TTM	-15.55%
Profit margin	0%
Book value	$3.65
Market Capitalization more info button	$794.5 million

TTM: trailing 12 months

Abcellera Biologics Inc stock dividends

We're not expecting Abcellera Biologics Inc to pay a dividend over the next 12 months.

Abcellera Biologics Inc stock price volatility

Over the last 12 months, Abcellera Biologics Inc's stocks have ranged in value from as little as $2.335 up to $6.055. A popular way to gauge a stock's volatility is its "beta."

Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Abcellera Biologics Inc's is 0.351. This would suggest that Abcellera Biologics Inc's stocks are less volatile than average (for this exchange).

Abcellera Biologics Inc overview

AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company's preclinical products are ABCL635 for metabolic and endocrine conditions; and ABCL575 for atopic dermatitis. It has a research collaboration and license agreement with Eli Lilly and Company; a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets; and strategic collaboration with Biogen Inc. to discover therapeutic antibodies for neurological conditions, as well as collaboration with Viking Global Investors and ArrowMark Partners. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Related: New to stock trading? Compare brokers and get tips for investing.

Frequently asked questions

What percentage of Abcellera Biologics Inc is owned by insiders or institutions?
Currently 27.928% of Abcellera Biologics Inc stocks are held by insiders and 39.785% by institutions. How many people work for Abcellera Biologics Inc?
Latest data suggests 586 work at Abcellera Biologics Inc. When does the fiscal year end for Abcellera Biologics Inc?
Abcellera Biologics Inc's fiscal year ends in December. Where is Abcellera Biologics Inc based?
Abcellera Biologics Inc's address is: 2215 Yukon Street, Vancouver, BC, Canada, V5Y 0A1 What is Abcellera Biologics Inc's ISIN number?
Abcellera Biologics Inc's international securities identification number is: CA00288U1066

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.